Finseta Group CEO James Hickman speaks with Giles Arbor about the company’s interim results, highlighting 16% revenue growth, the successful ramp-up of operations in Dubai and Canada, the launch of agency banking, and the Finseta corporate card...
ICFG Ltd’s Interim CEO, Enkhmaral Batkhuyag, shares insights on the company’s rapid growth from microfinance roots in Mongolia to its London Stock Exchange listing, regional expansion into Central Asia, and bold moves into digital insurance with the launch of MobiLife in partnership with MobiCom...
Roquefort Therapeutics Executive Chairman Stephen West discusses the company’s proposed £30 million reverse takeover of Coiled Therapeutics. The deal, supported by a £6 million investment from A2A Pharmaceuticals and its investors, will pivot Roquefort into a clinical-stage biotech, adding AO-252, a novel TACC3-targeting cancer therapy already in Phase I trials, to its pipeline...
Likewise Group CEO Tony Brewer reported strong H1 2025 results, with like-for-like sales up 10.2% in the first eight months. The company has expanded to 12 distribution centres, 152 delivery vehicles, and 99 sales executives, while also investing in new cutting facilities in Glasgow, Derby, and Newport to support future growth...
Dominic Smith, Marketing Director at Cerillion, discusses the company’s recent inclusion in Gartner’s Magic Quadrant and how embedded AI across its product suite is helping telecom providers streamline operations, personalise services, and accelerate growth...
Cora Gold CEO Bert Monro discusses the updated definitive feasibility study for the Sanankoro gold project in southern Mali. The revised study shows a 26% increase in reserves, extending mine life to 10 years, with projected average annual production of 65,000 ounces of gold...
Great Western Mining Executive Chairman Brian Hall has outlined upcoming drilling at the West Huntoon copper porphyry and the Rhyolite Dome gold prospect, alongside progress at Yellow Peak and tungsten work at Defender Pine Crow...
XP Factory CEO Richard Harpham spoke with DirectorsTalk about the company’s FY25 results. Revenue rose 19% on a comparable basis to nearly £58m, while EBITDA increased 30% to £6.6m. Both Escape Hunt and Boom Battle Bar delivered strong like-for-like sales growth, supported by customer demand and strategic site expansions...
Analyst Mark Thomas from Hardman & Co highlights the bank’s focus on low capital intensity and high risk-adjusted return businesses, disciplined credit practices, and plans to expand in underserved market segments...
TEAM Plc Executive Chairman Mark Clubb outlines the launch of the company’s new UCITS fund, highlighting its role in delivering cost-efficient investment solutions and supporting international growth...
Ilika CEO Graeme Purdy discusses the completion of manufacturing qualification for Stereax micro batteries at Cirtec’s US facility. With production underway, Ilika plans to begin customer deliveries by year-end. Purdy highlights the batteries’ compact, high-power design tailored for medical applications, and reinforces Cirtec’s strategic role in scaling commercial operations...
Meren Energy Inc. has reported its Q2 2025 results, with production in line with forecasts and updated guidance pointing towards the upper end of expectations...
EDX Medical has teamed up with Cambridge University Hospital's NHS Foundation Trust, the UK Health Security Agency, and other Cambridge institutions to create a rapid digital diagnostic for hospital-acquired pneumonia. The collaboration aims to deliver a reliable test that could save lives, reduce NHS costs, and improve patient outcomes, with development expected to complete later this year...
Verge Technologies CEO Jimmy Jobe explains how the company’s SentientDB platform delivers the first out-of-the-box solution for managing databases across multiple cloud and on-premises environments...
Graeme Purdy, Ilika Plc’s Chief Executive Officer, speaks to DirectorsTalk about the company’s strong year‑end results, the strategic alignment with Cirtec for Stereax manufacturing and the latest Goliath milestones...
Meren Energy, formerly Africa Oil, doubled reserves and production after acquiring 100% of Prime Oil & Gas. Nigerian deep-water assets deliver 38,000 boe/d and low costs, funding a tripled US $0.15 dividend, while Orange Basin projects move toward a 2026 FID...
CEO David Stirling and CFO Andrew Goody report FY to 29 March 2025: revenue just under £100m, EBITDA just under £7m, net debt down nearly £3m to below 2x EBITDA...
Ilika has secured £1.25m from the Advanced Propulsion Centre’s Demonstrate fund within the Government’s new £2.5bn Drive35 programme, supporting a £3m, 12-month PRIMED project with HSSMI and UKBIC to produce Goliath A-Samples...
MD Andrew Hume discusses the High Range surface geochemistry survey, which recorded hydrogen readings up to 3 000 ppm and helium up to six times background, confirming the presence of a working system...
Hardman & Co's Mark Thomas examines recent volatility trends, the robustness of collateralised loan obligations and the built‑in risk protections that support the company’s fundamental value...
Finseta Group CEO James Hickman speaks with Giles Arbor about the company’s interim results, highlighting 16% revenue growth, the successful ramp-up of operations in Dubai and Canada, the launch of agency banking, and the Finseta corporate card...
ICFG Ltd’s Interim CEO, Enkhmaral Batkhuyag, shares insights on the company’s rapid growth from microfinance roots in Mongolia to its London Stock Exchange listing, regional expansion into Central Asia, and bold moves into digital insurance with the launch of MobiLife in partnership with MobiCom...
Roquefort Therapeutics Executive Chairman Stephen West discusses the company’s proposed £30 million reverse takeover of Coiled Therapeutics. The deal, supported by a £6 million investment from A2A Pharmaceuticals and its investors, will pivot Roquefort into a clinical-stage biotech, adding AO-252, a novel TACC3-targeting cancer therapy already in Phase I trials, to its pipeline...
Likewise Group CEO Tony Brewer reported strong H1 2025 results, with like-for-like sales up 10.2% in the first eight months. The company has expanded to 12 distribution centres, 152 delivery vehicles, and 99 sales executives, while also investing in new cutting facilities in Glasgow, Derby, and Newport to support future growth...
Dominic Smith, Marketing Director at Cerillion, discusses the company’s recent inclusion in Gartner’s Magic Quadrant and how embedded AI across its product suite is helping telecom providers streamline operations, personalise services, and accelerate growth...
Cora Gold CEO Bert Monro discusses the updated definitive feasibility study for the Sanankoro gold project in southern Mali. The revised study shows a 26% increase in reserves, extending mine life to 10 years, with projected average annual production of 65,000 ounces of gold...
Great Western Mining Executive Chairman Brian Hall has outlined upcoming drilling at the West Huntoon copper porphyry and the Rhyolite Dome gold prospect, alongside progress at Yellow Peak and tungsten work at Defender Pine Crow...
XP Factory CEO Richard Harpham spoke with DirectorsTalk about the company’s FY25 results. Revenue rose 19% on a comparable basis to nearly £58m, while EBITDA increased 30% to £6.6m. Both Escape Hunt and Boom Battle Bar delivered strong like-for-like sales growth, supported by customer demand and strategic site expansions...
Analyst Mark Thomas from Hardman & Co highlights the bank’s focus on low capital intensity and high risk-adjusted return businesses, disciplined credit practices, and plans to expand in underserved market segments...
TEAM Plc Executive Chairman Mark Clubb outlines the launch of the company’s new UCITS fund, highlighting its role in delivering cost-efficient investment solutions and supporting international growth...
Ilika CEO Graeme Purdy discusses the completion of manufacturing qualification for Stereax micro batteries at Cirtec’s US facility. With production underway, Ilika plans to begin customer deliveries by year-end. Purdy highlights the batteries’ compact, high-power design tailored for medical applications, and reinforces Cirtec’s strategic role in scaling commercial operations...
Meren Energy Inc. has reported its Q2 2025 results, with production in line with forecasts and updated guidance pointing towards the upper end of expectations...
EDX Medical has teamed up with Cambridge University Hospital's NHS Foundation Trust, the UK Health Security Agency, and other Cambridge institutions to create a rapid digital diagnostic for hospital-acquired pneumonia. The collaboration aims to deliver a reliable test that could save lives, reduce NHS costs, and improve patient outcomes, with development expected to complete later this year...
Verge Technologies CEO Jimmy Jobe explains how the company’s SentientDB platform delivers the first out-of-the-box solution for managing databases across multiple cloud and on-premises environments...
Graeme Purdy, Ilika Plc’s Chief Executive Officer, speaks to DirectorsTalk about the company’s strong year‑end results, the strategic alignment with Cirtec for Stereax manufacturing and the latest Goliath milestones...
Meren Energy, formerly Africa Oil, doubled reserves and production after acquiring 100% of Prime Oil & Gas. Nigerian deep-water assets deliver 38,000 boe/d and low costs, funding a tripled US $0.15 dividend, while Orange Basin projects move toward a 2026 FID...
CEO David Stirling and CFO Andrew Goody report FY to 29 March 2025: revenue just under £100m, EBITDA just under £7m, net debt down nearly £3m to below 2x EBITDA...
Ilika has secured £1.25m from the Advanced Propulsion Centre’s Demonstrate fund within the Government’s new £2.5bn Drive35 programme, supporting a £3m, 12-month PRIMED project with HSSMI and UKBIC to produce Goliath A-Samples...
MD Andrew Hume discusses the High Range surface geochemistry survey, which recorded hydrogen readings up to 3 000 ppm and helium up to six times background, confirming the presence of a working system...
Hardman & Co's Mark Thomas examines recent volatility trends, the robustness of collateralised loan obligations and the built‑in risk protections that support the company’s fundamental value...
